Thryv (THRY) director John Slater adds 2,000 shares in open-market buy
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Thryv Holdings, Inc. director John Slater bought 2,000 common shares of the company in an open-market transaction at $2.66 per share. After this purchase, he directly holds 40,370 common shares. This filing reflects an additional personal investment by a board member rather than a sale or option exercise.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,000 shares ($5,320)
Net Buy
1 txn
Insider
Slater John
Role
Director
Bought
2,000 shs ($5K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Shares | 2,000 | $2.66 | $5K |
Holdings After Transaction:
Common Shares — 40,370 shares (Direct)
Footnotes (1)
FAQ
What insider transaction did Thryv (THRY) director John Slater report?
John Slater reported buying 2,000 Thryv common shares in an open-market transaction. The purchase, disclosed in a Form 4, shows he increased his direct ownership rather than selling or exercising derivatives, signaling a modest additional personal stake in the company.
Is John Slater’s Thryv (THRY) transaction a buy or a sell?
The transaction is a buy, specifically an open-market purchase of 2,000 common shares. The Form 4 codes it as a “P” transaction and identifies the direction as a net purchase, increasing his directly held stake in Thryv Holdings, Inc.
Does John Slater’s Thryv (THRY) filing involve options or derivatives?
No, the reported transaction involves only common shares, not options or other derivatives. The derivative position summary is empty, and the filing classifies the activity as a non-derivative, open-market common share purchase rather than an option exercise or conversion.
What does John Slater’s Thryv (THRY) open-market purchase indicate about his stake?
The open-market purchase modestly increases his direct equity stake in Thryv to 40,370 shares. While the size is relatively small, it shows a director committing additional personal capital rather than reducing exposure or merely receiving equity compensation.